References 1. United Nations World Tourism Organization (UNWTO). UNWTO Tourism Highlights 2019 Edition: UNWTO; 2019 [Available from: https://www.eunwto.org/doi/pdf/10.18111/9789284421152. 2. Committee for the Coordination of Statistical Activities (CCSA). How COVID-19 is changing the world: a statistical perspective. 2021. 3. Arcilla MS, van Hattem JM, Haverkate MR, Bootsma MCJ, van Genderen PJJ, Goorhuis A, et al. Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Lancet Infect Dis. 2017;17(1):78-85. 4. Voor In 't Holt AF, Mourik K, Beishuizen B, van der Schoor AS, Verbon A, Vos MC, et al. Acquisition of multidrug-resistant Enterobacterales during international travel: a systematic review of clinical and microbiological characteristics and meta-analyses of risk factors. Antimicrob Resist Infect Control. 2020;9(1):71. 5. Schaumburg F, Sertic SM, Correa-Martinez C, Mellmann A, Köck R, Becker K. Acquisition and colonization dynamics of antimicrobial-resistant bacteria during international travel: a prospective cohort study. Clin Microbiol Infect. 2019. 6. van der Zwaluw K, de Haan A, Pluister GN, Bootsma HJ, de Neeling AJ, Schouls LM. The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods. PLoS One. 2015;10(3):e0123690. 7. Wick RR, Judd LM, Gorrie CL, Holt KE. Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol. 2017;13(6):e1005595. 8. Kluytmans-van den Bergh MFQ, van Mens SP, Haverkate MR, Bootsma MCJ, Kluytmans J, Bonten MJM, et al. Quantifying Hospital-Acquired Carriage of Extended-Spectrum Beta-LactamaseProducing Enterobacteriaceae Among Patients in Dutch Hospitals. Infect Control Hosp Epidemiol. 2018;39(1):32-9. 9. Wuerz TC, Kassim SS, Atkins KE. Acquisition of extended-spectrum beta-lactamaseproducing Enterobacteriaceae (ESBL-PE) carriage after exposure to systemic antimicrobials during travel: Systematic review and meta-analysis. Travel Med Infect Dis. 2020;37:101823. 10. Reuland EA, Al Naiemi N, Kaiser AM, Heck M, Kluytmans JA, Savelkoul PH, et al. Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam. J Antimicrob Chemother. 2016;71(4):1076-82. 11. Peirano G, Laupland KB, Gregson DB, Pitout JD. Colonization of returning travelers with CTXM-producing Escherichia coli. J Travel Med. 2011;18(5):299-303. 12. Rodríguez I, Thomas K, Van Essen A, Schink AK, Day M, Chattaway M, et al. Chromosomal location of blaCTX-M genes in clinical isolates of Escherichia coli from Germany, The Netherlands and the UK. Int J Antimicrob Agents. 2014;43(6):553-7. 13. van den Bunt G, van Pelt W, Hidalgo L, Scharringa J, de Greeff SC, Schürch AC, et al. Prevalence, risk factors and genetic characterisation of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE): a community-based cross-sectional study, the Netherlands, 2014 to 2016. Euro Surveill. 2019;24(41). 14. van Kleef E, Wielders CCH, Schouls LM, Feenstra SG, Hertogh C, Bonten MJM, et al. National point prevalence study on carriage of multidrug-resistant microorganisms in Dutch long-term care facilities in 2018. J Antimicrob Chemother. 2021;76(6):1604-13. 15. Livermore DM, Day M, Cleary P, Hopkins KL, Toleman MA, Wareham DW, et al. OXA-1 βlactamase and non-susceptibility to penicillin/β-lactamase inhibitor combinations among ESBLproducing Escherichia coli. J Antimicrob Chemother. 2019;74(2):326-33. 16. Armand-Lefèvre L, Andremont A, Ruppé E. Travel and acquisition of multidrug-resistant Enterobacteriaceae. Med Mal Infect. 2018;48(7):431-41. 2 67 Pre-COVID-19 international travel and addmission to hospital back home
RkJQdWJsaXNoZXIy MTk4NDMw